Fragment-Based Drug Discovery: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
= Drug Design: Fragment-Based Drug Discovery = | = Drug Design: Fragment-Based Drug Discovery = | ||
<StructureSection load='' size='500' side='right' caption='Bcl-xl in complex with ABT-737 (PDB entry [[2yxj]])' scene='Sandbox_reserved_394/Bcl-xl_abt-737_complex/ | <StructureSection load='' size='500' side='right' caption='Bcl-xl in complex with ABT-737 (PDB entry [[2yxj]])' scene='Sandbox_reserved_394/Bcl-xl_abt-737_complex/6'> | ||
Traditionally, new drugs are developed by either making small changes to existing drugs or by individually testing thousands of compounds. Both of these methods require many hours of laborious chemical synthesis. However, new techniques are being applied in the drug industry which show promise in decreasing the cost and time required to discover and develop new drugs. | Traditionally, new drugs are developed by either making small changes to existing drugs or by individually testing thousands of compounds. Both of these methods require many hours of laborious chemical synthesis. However, new techniques are being applied in the drug industry which show promise in decreasing the cost and time required to discover and develop new drugs. | ||
